Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J OLDHAM

Showing results (301-310 of 307) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 307 results.
Immunotherapy Advances|September 22, 2025
CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axisLara V Graham, Ludmila Horehajova, Marco V Haselager, et al.
Cancer Immunology Research|September 26, 2025
A "Function-First" Approach to Identify Regulatory T cell-Targeting Antibodies for ImmunotherapyKirstie L S Cleary, Monika Semmrich, Linda Martensson, et al.
Nature Human Behaviour|February 23, 2026
A large mass grave from the Early Iron Age indicates selective violence towards women and children in the Carpathian BasinLinda Fibiger, Miren Iraeta-Orbegozo, Jovan Koledin, et al.
Immunity|June 25, 2026
Antibody binding geometry and affinity control inhibitory hFcγRIIB receptor signalingHayden Fisher, Emma J Sutton, Robert J Oldham, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2015
Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ ReceptorsAlison L Tutt, Sonya James, Stéphanie A Laversin, et al.
Cancer Cell|April 16, 2015
Antagonistic human FcγRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivoAli Roghanian, Ingrid Teige, Linda Mårtensson, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 8, 2022
HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapyKhiyam Hussain, Rena Liu, Rosanna C G Smith, et al.
Pageof 31

Showing results (301-310 of 307) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 307 results.
Immunotherapy Advances|September 22, 2025
CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axisLara V Graham, Ludmila Horehajova, Marco V Haselager, et al.
Cancer Immunology Research|September 26, 2025
A "Function-First" Approach to Identify Regulatory T cell-Targeting Antibodies for ImmunotherapyKirstie L S Cleary, Monika Semmrich, Linda Martensson, et al.
Nature Human Behaviour|February 23, 2026
A large mass grave from the Early Iron Age indicates selective violence towards women and children in the Carpathian BasinLinda Fibiger, Miren Iraeta-Orbegozo, Jovan Koledin, et al.
Immunity|June 25, 2026
Antibody binding geometry and affinity control inhibitory hFcγRIIB receptor signalingHayden Fisher, Emma J Sutton, Robert J Oldham, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2015
Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ ReceptorsAlison L Tutt, Sonya James, Stéphanie A Laversin, et al.
Cancer Cell|April 16, 2015
Antagonistic human FcγRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivoAli Roghanian, Ingrid Teige, Linda Mårtensson, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 8, 2022
HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapyKhiyam Hussain, Rena Liu, Rosanna C G Smith, et al.
Pageof 31